Improving patient safety while offering clinicians a more complete picture during interventional procedures, Toshiba America Medical Systems, Inc. will showcase Spot Fluoroscopy for its InfinixTM-i vascular X-ray systems at this year’s Society of Interventional Radiology (SIR) 2013 annual meeting.
Spot Fluoroscopy allows clinicians to observe a region of anatomy using live fluoroscopy while viewing the Last Image Hold (LIH) surrounding area, resulting in lower dose and a larger image display for quicker diagnoses.
“Spot Fluoroscopy changes visualization compared to conventional collimation with the ability to see inside and outside the region of interest in a single view,” said Allan Berthe, senior manager, Market Development, X-ray Vascular Business Unit, Toshiba. “The technology enables greater efficiency and safer procedures with the ability to reduce dose to patients and clinicians.”
Toshiba will also showcase its latest technologies to improve 3D and low-contrast imaging reconstruction speeds on its Infinix-i systems at SIR, New Orleans, April 13-18, 2013 (Booth #1013).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.